PMID: 7023307Sep 1, 1981Paper

Chenodiol (chenodeoxycholic acid) for dissolution of gallstones: the National Cooperative Gallstone Study. A controlled trial of efficacy and safety

Annals of Internal Medicine
L J Schoenfield, J M Lachin

Abstract

A double-masked study was conducted to determine the efficacy and safety of randomly allocated chenodiol (chenodeoxycholic acid, 750 mg/d or 350 mg/d) or placebo administered for 2 years to 916 patients for dissolution of radiolucent gallstones. There was confirmed complete dissolution in 13.5% of patients (750 mg/d), 5.2% (375 mg/d), and 0.8% (placebo), p less than 0.0001. Partial (over 50%) or complete dissolution (by validated roentgenographic metrology) occurred in 40.8% (750 mg/d), 23.6% (375 mg/d), and 11.0% (placebo), p less than 0.0001. Dissolution occurred more frequently in women, thin patients, or patients with small or floating gallstones or serum cholesterol greater than or equal to 227 mg/dL. Clinically significant hepatotoxicity occurred in 3% of patients (750 mg/d), 0.4% (375 mg/d), and 0.4% (placebo), p less than 0.007, and always was reversible biochemically. Elevations of 10% or more of serum cholesterol, mostly low-density lipoproteins, occurred in 85.2% of patients (750 mg/d), 82.8% (375 mg/d), and 67.0% (placebo), p less than 0.001. Chenodiol, 750 mg/d for up to 2 years, is appropriate therapy for dissolution of gallstones in selected patients who are informed of the risks and benefits.

Citations

Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S TomidaT Osuga
Jan 1, 1993·Journal of Clinical Laboratory Analysis·S C KazmierczakD R Sinar
Jan 1, 1987·Cancer Chemotherapy and Pharmacology·D Griffin, H M Said
Oct 1, 1986·Digestive Diseases and Sciences·S K SarinR K Tandon
Sep 1, 1993·Digestive Diseases and Sciences·A ButtmannJ F Riemann
Dec 1, 1984·Digestive Diseases and Sciences·K MiyazakiA Koga
Sep 1, 1982·Digestive Diseases and Sciences·W H Bachrach, A F Hofmann
Sep 1, 1982·Digestive Diseases and Sciences·J L Thistle
Jul 1, 1989·Digestive Diseases and Sciences·R R SchadeR L Wechsler
Dec 1, 1989·Digestive Diseases and Sciences·A RodaB Natalini
Dec 1, 1989·Digestive Diseases and Sciences·H Fromm
Dec 1, 1989·Digestive Diseases and Sciences·M PoddaM Zuin
Jan 1, 1985·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·H K SeitzS Veith
Jan 1, 1990·Gastrointestinal Radiology·P JanowitzH Ditschuneit
May 1, 1994·Digestive Diseases and Sciences·J Y SungJ W Costerton
Sep 1, 1994·Digestive Diseases and Sciences·J W MarksL J Schoenfield
Jan 1, 1990·Surgical Endoscopy·D P GriffithM J Gleeson
Mar 1, 1984·Irish Journal of Medical Science·S C MulliganO I Corrigan
Dec 2, 2006·European Journal of Drug Metabolism and Pharmacokinetics·M MikovS Kevresan
Feb 1, 1987·American Journal of Surgery·H A PittT R Gadacz
Sep 1, 1989·American Journal of Surgery·R V RegeD L Nahrwold
Sep 1, 1989·American Journal of Surgery·D VanderpoolJ K Hamilton
Jul 1, 1991·Seminars in Roentgenology·R L Baron
May 1, 1985·Steroids·E SacquetR Infante
Nov 2, 1991·Lancet·T Sauerbruch, G Paumgartner
Jan 1, 1983·Pharmacology & Therapeutics·G D Bell
Jan 1, 1989·Pharmacology & Therapeutics·E J van HoogdalemD D Breimer
Jan 1, 1992·Pharmacology & Therapeutics·E RodaA Roda
Apr 1, 1995·Pharmacology & Therapeutics·R Poupon, R E Poupon
Dec 1, 1983·Controlled Clinical Trials·P L CannerS A Forman
Jan 11, 1991·Comparative Biochemistry and Physiology. A, Comparative Physiology·G BroughtonE L Rongone
Apr 1, 1993·American Journal of Surgery·L J Schoenfield, J W Marks
Aug 3, 2001·Primary Care·A N Kalloo, S V Kantsevoy

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.